Lawrence Bloch
Chief Executive Officer presso NeurAxon Pharma, Inc.
Patrimonio netto: 97 $ in data 31/01/2024
Profilo
Lawrence E.
Bloch currently works at NeurAxon Pharma, Inc., as President & Chief Executive Officer.
Dr. Bloch also formerly worked at NeurAxon, Inc., as President, Chief Executive Officer & Director in 2011, Applied Molecular Evolution, Inc., as Chief Financial Officer & VP-Business Development from 1999 to 2004, NitroMed, Inc., as Chief Financial & Business Officer in 2006, and Infinity Pharmaceuticals, Inc., as President & Treasurer from 2017 to 2023.
Dr. Bloch received his doctorate degree from Harvard Medical School, Masters Business Admin degree from Harvard Business School, and graduate degree from Harvard Law School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/05/2023 | 966 932 ( 1.07% ) | 97 $ | 31/01/2024 |
Posizioni attive di Lawrence Bloch
| Società | Posizione | Inizio |
|---|---|---|
NeurAxon Pharma, Inc.
 NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | Chief Executive Officer | - |
Precedenti posizioni note di Lawrence Bloch
| Società | Posizione | Fine |
|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | President | 31/03/2023 |
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Chief Executive Officer | 01/01/2011 |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Director of Finance/CFO | 01/01/2006 |
Applied Molecular Evolution, Inc.
 Applied Molecular Evolution, Inc. Medical/Nursing ServicesHealth Services Applied Molecular Evolution, Inc. provides healthcare support services. It develops novel human biotherapeutics cytokines, hormones, and enzymes. The company was founded in 1989 by Bill Huse and is headquartered in San Diego, CA. | Director of Finance/CFO | - |
Formazione di Lawrence Bloch
| Harvard Medical School | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
| Harvard Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Applied Molecular Evolution, Inc.
Applied Molecular Evolution, Inc. Medical/Nursing ServicesHealth Services Applied Molecular Evolution, Inc. provides healthcare support services. It develops novel human biotherapeutics cytokines, hormones, and enzymes. The company was founded in 1989 by Bill Huse and is headquartered in San Diego, CA. | Health Services |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Commercial Services |
NeurAxon Pharma, Inc.
NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | Commercial Services |
- Borsa valori
- Insiders
- Lawrence Bloch
